XF
REGN icon

XML Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

XML Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$757K Buy
1,214
+44
+4% +$29.9K 0.06% 226
2026
Q1 		$904K Buy
1,170
+85
+8% +$65.1K 0.07% 191
2025
Q4 		$838K Sell
1,085
-40
-4% -$27.2K 0.07% 197
2025
Q3 		$633K Buy
1,125
+520
+86% +$294K 0.05% 227
2025
Q2 		$318K Buy
605
+13
+2% +$7.26K 0.03% 298
2025
Q1 		$375K Sell
592
-452
-43% -$311K 0.04% 261
2024
Q4 		$744K Sell
1,044
-63
-6% -$52.9K 0.07% 194
2024
Q3 		$1.16M Sell
1,107
-100
-8% -$111K 0.11% 158
2024
Q2 		$1.27M Sell
1,207
-30
-2% -$29.1K 0.13% 142
2024
Q1 		$1.19M Sell
1,237
-20
-2% -$19K 0.12% 151
2023
Q4 		$1.1M Buy
1,257
+48
+4% +$39.5K 0.12% 153
2023
Q3 		$995K Sell
1,209
-16
-1% -$12.6K 0.12% 152
2023
Q2 		$880K Buy
1,225
+61
+5% +$47K 0.1% 170
2023
Q1 		$956K Sell
1,164
-90
-7% -$67.9K 0.12% 151
2022
Q4 		$905K Sell
1,254
-30
-2% -$22.1K 0.11% 155
2022
Q3 		$885K Buy
1,284
+52
+4% +$32.7K 0.12% 149
2022
Q2 		$728K Buy
1,232
+160
+15% +$104K 0.16% 110
2022
Q1 		$749K Buy
1,072
+89
+9% +$56.3K 0.09% 175
2021
Q4 		$621K Sell
983
-20
-2% -$12.3K 0.07% 184
2021
Q3 		$607K Buy
1,003
+105
+12% +$65.2K 0.08% 184
2021
Q2 		$502K Buy
898
+3
+0.3% +$1.52K 0.11% 143
2021
Q1 		$423K Buy
895
+268
+43% +$130K 0.1% 146
2020
Q4 		$303K Buy
627
+5
+0.8% +$2.7K 0.08% 163
2020
Q3 		$348K Sell
622
-100
-14% -$60.6K 0.11% 140
2020
Q2 		$450K Sell
722
-131
-15% -$74.4K 0.16% 107
2020
Q1 		$417K Buy
853
+13
+2% +$5.36K 0.18% 99
2019
Q4 		$315K Buy
+840
New +$283K 0.11% 136

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

XML Financial's REGN Position: Q2 2026 in Review

XML Financial increased its Regeneron Pharmaceuticals (REGN) stake by 3.8% in Q2 2026, buying an estimated $29.9K and bringing the position to 1,214 shares worth $757K. The position accounts for 0.06% of the portfolio, ranked #226.

XML Financial first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.27M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • XML Financial held 1,214 shares of Regeneron Pharmaceuticals worth $757K as of Q2 2026.
  • XML Financial bought 44 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $29.9K.
  • Regeneron Pharmaceuticals made up 0.06% of XML Financial's portfolio in Q2 2026, its #226 holding.
  • XML Financial first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • XML Financial's Regeneron Pharmaceuticals position peaked at $1.27M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.